|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS11312|
Dialysis Market Overview
The global dialysis market is predicted to grow considerably in the coming years, on account of the rising prevalence of hypertension and diabetes, increasing number of people suffering from end-stage renal disease (ESRD), and surge in the funding for product development. Dialysis refers to the artificial process of removing waste from the body, by purifying the blood, in cases where the kidneys are not performing their natural function.
Peritoneal dialysis, where the lining of the abdomen is used to clean the blood, and hemodialysis, wherein the blood is taken from the body and then cleaned in a machine, are the two types of dialysis generally done at healthcare settings. The former process is further of the automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) types, while the latter process is of the short daily hemodialysis, conventional hemodialysis, and nocturnal hemodialysis kinds. Of these, hemodialysis is expected to witness robust progress in the dialysis market in the coming years.
This is because of the increasing incidence of renal disease in adults and the elderly. Further, hemodialysis needs to performed only thrice a week, which is why the majority of patients with impaired kidney function prefer it. Additionally, fewer people know about the peritoneal variant, which further results in the higher dialysis market share of hemodialysis. Consumables and machines are the major products available for hemodialysis, and access products, dialyzers, concentrates, and blood lines are the most widely sold consumables. Similarly, the peritoneal process is performed with machines, concentrates/dialysates, transfer sets, and catheters.
Home dialysis and in-center dialysis are the two major end users of the process, of which in-center dialysis accounted for the larger dialysis market size in the historical period. This is because in-center dialysis is performed at hospitals and other healthcare settings by skilled professionals, which is why the majority of patients prefer that over at-home treatment. Further, should anything go wrong, the trained professionals at healthcare centers are able to diagnose the issue and rectify it swiftly, which is not always possible at homes.
Geographically, the dialysis market in the U.S. would observe considerable CAGR in the near future, due to the large number of kidney disease patients. Additionally, several major market players exist or are based in the country, and many of them are pursuing technological advancements, which further leads to its high industry share. The favorable imbursement scenario lets a major chunk of the population afford these otherwise-costly treatments. Germany is another country which is expected to observe healthy progress in the coming years.
Dialysis Market Dynamics
A prominent trend in the global dialysis market is the usage of peritoneal dialysis, as the products used for it are portable, thereby leading to convenience, especially at patients’ homes. As it does not necessarily require the patient to be awake, it can also be performed during sleep, which is further driving its popularity, especially among the elderly. This is resulting in numerous industry players coming up with products for peritoneal dialysis and some also undertaking research and development (R&D) to advance the technology.
The most significant dialysis market growth driver is the rise in the number of people suffering from renal disorders, such as kidney failure, caused by trauma, age, cancer, or diabetes. According to the Global Burden of Disease 2015 report by the World Health Organization (WHO), in 2010, lack of chronic dialysis led to around 7.1 million deaths. The WHO also estimates the annual mortality due to renal diseases at 5 million. Therefore, with the increase in the number of kidney disease patients, the demand for dialysis is also surging.
Apart from physical trauma, kidney failure can be brought on by renal cancer, infection, and certain autoimmune diseases, such as Erdheim–Chester disease and amyloidosis. One of the most common causes of compromised renal function is diabetes, with the number of those suffering from it growing to 422 million in 2014 from 108 million in 1980, as per the WHO. Renal cancer is another significant reason behind the kidney failure; 400,000 cases of the disease were diagnosed across the world in 2018, as per the World Cancer Research Fund. Therefore, with the increasing incidence of such disorders, the dialysis market is observing progress.
Dialysis Market Competitive Landscape
The key players in the industry are launching improved products and pursuing regulatory approvals to have an edge over the competition. For instance, in August 2017, the Diacap Pro dialyzer developed by B. Braun Melsungen was approved by the U.S. Food and Drug Administration (FDA). Among the features of this product are better user-friendliness and clearance performance. The major dialysis market players are DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd., B. Braun Melsungen AG, Medivators Inc., Asahi Kasei Corporation, Diaverum Deutschland GmbH, NxStage Medical Inc., Baxter International Inc., and Nipro Corporation.
Market Size Breakdown by Segment
Based on System
Based on Product & Services
Based on End User